Employing one-sided P values , addition of either carboplatin ( @ % v @ % ; P = @ ) or bevacizumab ( @ % v @ % ; P = @ ) significantly increased pCR breast , whereas only carboplatin ( @ % v @ % ; P = @ ) significantly raised pCR breast/axilla .